EUnetHTA Joint Action 3 (2016 – 2020)

Home  /  Activities   /  EUnetHTA Joint Action 3 (2016 – 2020) (Page 7)

We are pleased to announce that the collaborative rapid assessment, OTCA11, on :“Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcomes in patients undergoing knee, maxillofacial, or cranial surgery”

Assistant Project Manager Place: Diemen, Netherlands Contract duration: 2 years Hours per week: 36 Monthly salary: €2,631 - € 4,229 Salary level: scale 10 Level: bachelor Respond before: 12 November to Job Number: 2018054436 Placement date: 29 October 2018 Employment: Temporary employment Job description Description of functions / tasks The Assistant Project

​We are pleased to announce that the collaborative rapid assessment on "Femtosecond laser-assisted cataract surgery (FLACS) for the treatment of age-related cataract" is available. The health technology assessed a computer-controlled laser system to complete various steps of cataract surgery. The objective

"HTA cooperation produces and will produce very tangible benefits not only for patients, but also improve the quality and sustainability of health systems when Europe needs them most."  [vc_row][vc_column][vc_single_image image="15600" img_size="large"][vc_column_text] [pdf-embedder url="" title="Summer_2018_Magazine - 2 Photos, Sidebar, and 1 Column"][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]

The final project plan of the assessment on “Bioresorbable Stents in cardiovascular indications (coronary artery disease)” and the comments provided by the external experts and the manufacturers are now available. OTCA16 Project Plan HERE OTCA16 External Expert and Manufacturer Comments HERE

We are pleased to announce that the joint rapid assessment on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is available. The health technologies assessed include rtCGM